WCM
TMO icon

Weaver Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Weaver Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$725K Hold
1,476
– – 0.16% 109
2026
Q1 		$725K Buy
1,476
+30
+2% +$16.3K 0.16% 111
2025
Q4 		$838K Buy
1,446
+402
+39% +$227K 0.18% 113
2025
Q3 		$506K Buy
+1,044
New +$486K 0.11% 128

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Weaver Capital Management's TMO Position: Q2 2026 in Review

Weaver Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,476 shares worth $725K. The position accounts for 0.16% of the portfolio, ranked #109.

Weaver Capital Management first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. The position peaked at $838K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Weaver Capital Management held 1,476 shares of Thermo Fisher Scientific worth $725K as of Q2 2026.
  • Weaver Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.16% of Weaver Capital Management's portfolio in Q2 2026, its #109 holding.
  • Weaver Capital Management first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • Weaver Capital Management's Thermo Fisher Scientific position peaked at $838K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Weaver Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.